Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vein911 is a private, physician-led specialty vein treatment company focused on diagnosis and minimally invasive treatment of venous and lymphatic disorders. The company operates multi-site outpatient vein clinics in the Tampa Bay area and provides medical and cosmetic vein care, including endovenous laser therapy, ultrasound-guided foam/visual sclerotherapy, and VeinGogh-based treatments for small visible veins. Vein911 emphasizes education-first care, outpatient procedures with little downtime, and physician training and research in venous and lymphatic medicine. Its branded VenaThrive protocol is marketed as a comprehensive, non-surgical approach for treating abnormal veins and improving both symptom relief and cosmetic outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vein911.